When a company such as Dr. Reddys Laboratories splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the RDY split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Dr. Reddys Laboratories shares, starting with a $10,000 purchase of RDY, presented on a split-history-adjusted basis factoring in the complete RDY split history.

About Dr. Reddys Laboratories

Dr. Reddy's Laboratories is a pharmaceutical company. Co.'s segments include: Global Generics, which includes its business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics); Pharmaceutical Services and Active Ingredients, which includes its business of manufacturing and marketing active pharmaceutical ingredients and intermediates; and Proprietary Products, which includes its business that focuses on the research and development of differentiated formulations. According to our RDY split history records, Dr. Reddys Laboratories has had 1 split.

RDY Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved